The implementation of scientifically proven HIV prevention strategies is helping to reduce the number of new infections — the annual HIV infection rate globally fell by 22 percent from 2001 to 2011 — but a great deal more must be done. Significant scale-up of proven HIV prevention strategies coupled with the discovery of new HIV...
As we celebrate Asian Americans and Pacific Islanders (AAPI) Heritage Month and the many accomplishments of AAPIs, we also want to recognize that these communities still face many barriers to health and health care, including HIV/AIDS. To recognize these challenges, May 19th has been designated as the National Asian & Pacific Islander HIV/AIDS Awareness Day....
May 18th is HIV Vaccine Awareness Day (HVAD), led by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. We spoke to Dr. Carl Dieffenbach at NIH, who had this to say about HIV Vaccine Awareness Day: “[On Vaccine Awareness Day] we can take a moment to acknowledge the...
This week, we mark the second annual observance of Hepatitis Testing Day. Establishment of this national health awareness day on May 19 was called for in the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis as part of efforts to decrease health disparities by raising greater public and health care provider awareness,...
The Banyan Tree Project launched Taking Root: Our Stories, Our Community last year for May 19, the National Asian & Pacific Islander (A&PI) HIV/AIDS Awareness Day. Taking Root puts the power to end HIV stigma back in the hands of the community through a community-driven, community-owned digital storytelling initiative. Since then, we have held four...
Considering everything else to there is to deal with when treating a HIV-positive woman, it might be all too easy to let one simple priority slide: the Pap smear.
The first multicohort prospective study of HIV and cervical cancer offers sobering cause to reorient priorities. HIV-infected women have a higher incidence of precancerous cervical lesions.
The risk increases significantly as CD4 counts decrease.
To suggest today that condoms are “obsolete” sounds heretical and like a topic ripe for heated debate. Here, HIV/AIDS blogger Dr. Rodger MacArthur lays out the science for your review. More »
Numerous short- and long-term adjustments are underway to address an anticipated shortage in HIV care clinicians. One of the important alternatives may be shifting more care to nurses. More »
(AUDIO) The HIV Medicine Association has released a document that identifies the key characteristics of a medical provider qualified to manage the long-term care of patients infected with HIV. Here the chair of the organization describes the qualifications and tells why they are important. More »
Key points for primary care physicians from a new study: HIV-positive women are vulnerable to invasive cervical cancer. This finding underscores the need for screening per guidelines and to follow-up on abnormal Pap smears. More »
Managing chronic disease and HIV in the over-50 population leads to a high risk of adverse drug interactions. Here are the most common polypharmacy culprits for HIV patients, and tips for avoiding these dangerous mishaps. More »
Implementation of the Patient Protection and Affordable Care Act is largely good news for patients with HIV, many of whom have been denied coverage under preexisting condition clauses. However, some questions and some gaps in coverage remain to be addressed. More »
When the FDA approved pre-exposure prophylaxis for HIV prevention, observers wondered whether or not the strategy was cost effective. A study has now analyzed the question. Answer: It depends. More »
(AUDIO) How often should people be (re)tested for HIV? A pair of industrial efficiency experts looked at current HIV testing recommendations, and found them too conservative. More »
More than half of people with HIV infection in the United States develop head and neck lesions. Common among these is enlargement of the parotid gland, which causes disfigurement and therefore distress. This review discusses the evidence for radiation treatment as the best option, as well as the dangers of choosing the wrong treatment for this benign comorbidity of HIV-positive status.
A 20-year-old HIV positive male presents with headache, nausea, and vomiting following a seizure. History is notable for 3 surgeries to remove colonic polyps. Subsequent MRI brain scan with contrast reveals a mass in the left frontal lobe which is removed. The image above is an H&E stained section of the mass.
A 50-year-old African American man with HIV infection had a CD4+ T-cell count of 18/μL (1%), CD8+ cell count of 1035/μL (69%), and CD4:CD8 ratio of 0.01 at the time of diagnosis. He had multiple erythematosquamous skin lesions over his forehead, face, chest, back, and extremities
Herpes zoster, or shingles, is characterized by unilateral radicular pain and a vesicular rash that is generally limited to a single dermatome. It results from reactivation of latent varicella-zoster virus (VZV) within the sensory ganglia.
The introduction of HAART (highly-active-antiretroviral-therapy) has resulted in extended survival of HIV positive patients. Conversely, due to the prolonged expectancy of life and the ageing of the HIV positive population, tumors are now one of the major cause of death, and among them hepatocellular carcinoma (HCC) has become a growing concern in these patients. Considering the potential anti-tumoral effects of HIV protease inhibitors, we decided to evaluate the anti-tumoral activity of Amprenavir on liver carcinoma and to evaluate its potential synergistic effects in combination with standard chemoterapic drugs, such as Doxorubicin. Our results indicate that Amprenavir had direct inhibitory effects on invasion of Huh-7 hepatocarcinoma cell lines, inhibiting MMP proteolytic activation. Amprenavir was able to delay the growth of hepatocarcinoma xenografts in nude mice and had a synergistic effect with Doxorubicin. Furthermore, Amprenavir was able to promote regression of
23403670 2013 02 13 2013 02 19 1538-3598 309 6 Feb 13 JAMA 545-6 10.1001/jama.2012.216991 Padayatty Sebastian J SJ Levine Mark M eng Comment Letter United States JAMA 7501160 0098-7484 0 Vitamins 12001-76-2 Vitamin B Complex 1406-18-4 Vitamin E 50-81
23403671 2013 02 13 2013 02 19 1538-3598 309 6 Feb 13 JAMA 546 10.1001/jama.2012.216995 Isanaka Sheila S Mugusi Ferdinand F Fawzi Wafaie W WW eng Comment Letter United States JAMA 7501160 0098-7484 0 Vitamins 12001-76-2 Vitamin B Complex 1406-18-4
Primary Care Can't Thrive Without Nurse Practitioners Courtney H. Lyder, ND, May 17, 2013 With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.